Канал: T2 Biosystems Inc

2024 Sepsis Alliance Summit T2 Biosystems Session

2024 Sepsis Alliance Summit T2 Biosystems Session

2024 ASM T2 Biosystems Industry and Science Showcase

2024 ASM T2 Biosystems Industry and Science Showcase

Innovation Theater at ESCMID Global 2024: Klinik Favoriten

Innovation Theater at ESCMID Global 2024: Klinik Favoriten

Innovation Theater at ESCMID Global 2024: Wayne State University

Innovation Theater at ESCMID Global 2024: Wayne State University

2024 Society of Critical Care Medicine: Oral Poster Presentation

2024 Society of Critical Care Medicine: Oral Poster Presentation

T2 Biosystems Learning Lounge IDWeek 2023

T2 Biosystems Learning Lounge IDWeek 2023

2023 Sepsis Alliance Summit Industry Session

2023 Sepsis Alliance Summit Industry Session

WEBINAR: Optimize Sepsis Testing with Culture Independent Diagnostics

WEBINAR: Optimize Sepsis Testing with Culture Independent Diagnostics

2023 ASM Industry and Science Showcase

2023 ASM Industry and Science Showcase

ECCMID 2023 Oral Session: Diagnosis of Bloodstream Infections and Sepsis

ECCMID 2023 Oral Session: Diagnosis of Bloodstream Infections and Sepsis

T2 Biosystems Innovation Theater ECCMID 2023

T2 Biosystems Innovation Theater ECCMID 2023

In-Booth Presentation ECCMID 2023

In-Booth Presentation ECCMID 2023

Sepsis: Improving clinical outcomes and the power of new rapid diagnostics

Sepsis: Improving clinical outcomes and the power of new rapid diagnostics

2021 Sepsis Alliance Summit Industry Session

2021 Sepsis Alliance Summit Industry Session

2021 Sepsis Alliance Summit Opening Remarks

2021 Sepsis Alliance Summit Opening Remarks

T2 Biosystems Integrated Symposium ECCMID 2022

T2 Biosystems Integrated Symposium ECCMID 2022

Optimizing Sepsis Management with T2 Biosystems

Optimizing Sepsis Management with T2 Biosystems

2022 Sepsis Alliance Summit Innovation Session

2022 Sepsis Alliance Summit Innovation Session

T2SARS-CoV-2 Demo

T2SARS-CoV-2 Demo

Integrated Symposium at ECCMID 2021

Integrated Symposium at ECCMID 2021

Q&A Session: Integrated Symposium at ECCMID 2021

Q&A Session: Integrated Symposium at ECCMID 2021

Industry Keynote at Sepsis Tech and Innovation

Industry Keynote at Sepsis Tech and Innovation

Industry & Science Symposium: World Microbe Forum

Industry & Science Symposium: World Microbe Forum

T2Dx Instrument Demo

T2Dx Instrument Demo

T2 Biosystems Reminds Stockholders to Vote at the Upcoming Annual Meeting

T2 Biosystems Reminds Stockholders to Vote at the Upcoming Annual Meeting

Big Biz Show, Clip 2

Big Biz Show, Clip 2

Big Biz Show, Clip 1

Big Biz Show, Clip 1

Video How T2MR Works

Video How T2MR Works

T2 Biosystems Sepsis Awareness Month 2020

T2 Biosystems Sepsis Awareness Month 2020

WEBINAR: COVID 19 and the Impact of Secondary and Co infections

WEBINAR: COVID 19 and the Impact of Secondary and Co infections

T2 Biosystems Overview

T2 Biosystems Overview

T2 Biosystems Keynote Presentation at the World Anti-Microbial Resistance Congress 2019

T2 Biosystems Keynote Presentation at the World Anti-Microbial Resistance Congress 2019

Rapid, Direct-from-Blood Diagnostics that Enable Changes in Clinical Decisions

Rapid, Direct-from-Blood Diagnostics that Enable Changes in Clinical Decisions

A Rapid, Direct-from-Blood Diagnostic to Address Infections from Multidrug Resistant Organisms

A Rapid, Direct-from-Blood Diagnostic to Address Infections from Multidrug Resistant Organisms

Rapid Species Identification Using T2Direct Diagnostics™ with Stewardship Interventions

Rapid Species Identification Using T2Direct Diagnostics™ with Stewardship Interventions

T2Dx Instrument Demonstration at ECCMID 2019

T2Dx Instrument Demonstration at ECCMID 2019

Species ID from sepsis causing pathogens in 3 to 5 hours, days faster than blood culture

Species ID from sepsis causing pathogens in 3 to 5 hours, days faster than blood culture

T2 Biosystems Presentation at PACCARB Meeting 2019

T2 Biosystems Presentation at PACCARB Meeting 2019

Novel rapid diagnostic for sepsis causing infections Clinical utility & routine application

Novel rapid diagnostic for sepsis causing infections Clinical utility & routine application

Part 2: Earlier Effective Antibiotic Therapy Through Culture Independent Diagnostics- SCCM 2019

Part 2: Earlier Effective Antibiotic Therapy Through Culture Independent Diagnostics- SCCM 2019

Part 1: Earlier Effective Antibiotic Therapy Through Culture Independent Diagnostics- SCCM 2019

Part 1: Earlier Effective Antibiotic Therapy Through Culture Independent Diagnostics- SCCM 2019

Mary Millard, Sepsis Survivor and Patient Advocate

Mary Millard, Sepsis Survivor and Patient Advocate

AMR 2018 – Keynote: Antimicrobial Therapy for Life-Threatening Infections

AMR 2018 – Keynote: Antimicrobial Therapy for Life-Threatening Infections

AMP 2017 – Chiagozie Ononye, M.D. – T2Bacteria RUO Patient Population

AMP 2017 – Chiagozie Ononye, M.D. – T2Bacteria RUO Patient Population

AMP 2017 – Chiagozie Ononye, M.D. – T2Bacteria RUO Application

AMP 2017 – Chiagozie Ononye, M.D. – T2Bacteria RUO Application

AMP 2017 – Chiagozie Ononye, M.D. - T2Bacteria RUO Case Study 4

AMP 2017 – Chiagozie Ononye, M.D. - T2Bacteria RUO Case Study 4

AMP 2017 – Chiagozie Ononye, M.D. - T2Bacteria RUO Case Study 2

AMP 2017 – Chiagozie Ononye, M.D. - T2Bacteria RUO Case Study 2

AMP 2017 - Tom Lowery, Ph.D. - T2MR: A New Standard in Sepsis Workflow

AMP 2017 - Tom Lowery, Ph.D. - T2MR: A New Standard in Sepsis Workflow

AMP 2017 - Tom Lowery, Ph.D. - T2MR: Proven Rapid Time to Result

AMP 2017 - Tom Lowery, Ph.D. - T2MR: Proven Rapid Time to Result

AMP 2017 - Chiagozie Ononye, M.D. - T2Bacteria RUO Case Study 1

AMP 2017 - Chiagozie Ononye, M.D. - T2Bacteria RUO Case Study 1

AMP 2017 - Chiagozie Ononye, M.D. - Potential Clinical Impact of the T2Bacteria RUO Panel

AMP 2017 - Chiagozie Ononye, M.D. - Potential Clinical Impact of the T2Bacteria RUO Panel

AMP 2017 - Chiagozie Ononye, M.D. - T2Bacteria RUO Case Study 3

AMP 2017 - Chiagozie Ononye, M.D. - T2Bacteria RUO Case Study 3

AMP 2017 - Chiagozie Ononye, M.D. - T2Bacteria RUO Case Study 5

AMP 2017 - Chiagozie Ononye, M.D. - T2Bacteria RUO Case Study 5

AMP 2017 - Tom Lowery, Ph.D. - T2Sepsis Solution

AMP 2017 - Tom Lowery, Ph.D. - T2Sepsis Solution

AMP 2017 - Chiagozie Ononye, M.D. - Early Experience with the T2Bacteria Panel RUO

AMP 2017 - Chiagozie Ononye, M.D. - Early Experience with the T2Bacteria Panel RUO

IDWeek 2017, Cornelius J. Clancy - Conclusion of T2Candida Study

IDWeek 2017, Cornelius J. Clancy - Conclusion of T2Candida Study

IDWeek 2017, Glen T. Hansen. Ph.D. - Importance of Rapid ID

IDWeek 2017, Glen T. Hansen. Ph.D. - Importance of Rapid ID

IDWeek 2017, Glen T. Hansen, Ph.D. - T2Bacteria Panel Coverage

IDWeek 2017, Glen T. Hansen, Ph.D. - T2Bacteria Panel Coverage

IDWeek 2017, Glen T. Hansen, Ph.D. - T2Bacteria RUO Case Studies from Italy

IDWeek 2017, Glen T. Hansen, Ph.D. - T2Bacteria RUO Case Studies from Italy

IDWeek 2017, Glen T. Hansen, Ph.D. - T2MR Detects Infections Missed by Blood Culture

IDWeek 2017, Glen T. Hansen, Ph.D. - T2MR Detects Infections Missed by Blood Culture

IDWeek 2017 , Corneilus J. Clancy, M.D. - Predictive Value of the T2Candida Panel

IDWeek 2017 , Corneilus J. Clancy, M.D. - Predictive Value of the T2Candida Panel

IDWeek 2017 - Cornelius J. Clancy, M.D: T2Candida v. Blood Culture

IDWeek 2017 - Cornelius J. Clancy, M.D: T2Candida v. Blood Culture

IDWeek 2017 - Glen T. Hansen, Ph.D: T2Bacteria: Early Experience

IDWeek 2017 - Glen T. Hansen, Ph.D: T2Bacteria: Early Experience

IDWeek 2017 - Cornelius J. Clancy, M.D: T2Sepsis Solution: Direct from Whole Blood Diagnostics

IDWeek 2017 - Cornelius J. Clancy, M.D: T2Sepsis Solution: Direct from Whole Blood Diagnostics

ECCMID 2017 - Patricia Muñoz, MD, PhD: Identifying Complicated Candidemia

ECCMID 2017 - Patricia Muñoz, MD, PhD: Identifying Complicated Candidemia

ECCMID 2017 - Patricia Muñoz, MD, PhD: Good Outcomes vs Bad Outcomes

ECCMID 2017 - Patricia Muñoz, MD, PhD: Good Outcomes vs Bad Outcomes

ASM Microbe 2017 - Mitchell J. Cohen, MD: Faster Antifungal Therapy

ASM Microbe 2017 - Mitchell J. Cohen, MD: Faster Antifungal Therapy

ASM Microbe 2017 - Mitchell J. Cohen, MD: T2Bacteria in the Emergency Department

ASM Microbe 2017 - Mitchell J. Cohen, MD: T2Bacteria in the Emergency Department

ASM Microbe 2017 - Thomas Kirn, MD, PHD: T2Bacteria Case Studies Clinical Trial

ASM Microbe 2017 - Thomas Kirn, MD, PHD: T2Bacteria Case Studies Clinical Trial

ECCMID 2017 - Sandy J. Estrada, Pharm.D., BCPS: T2Candida Case Study 2

ECCMID 2017 - Sandy J. Estrada, Pharm.D., BCPS: T2Candida Case Study 2

ECCMID 2017- Sandy J. Estrada, Pharm.D., BCPS: T2Candida Case Study 3

ECCMID 2017- Sandy J. Estrada, Pharm.D., BCPS: T2Candida Case Study 3

ECCMID 2017 - Sandy J. Estrada, Pharm.D., BCPS: T2Candida Case Study 1

ECCMID 2017 - Sandy J. Estrada, Pharm.D., BCPS: T2Candida Case Study 1

ASM Microbe 2017 - Thomas Kirn, MD, PHD: Order T2Candida when Ordering BC

ASM Microbe 2017 - Thomas Kirn, MD, PHD: Order T2Candida when Ordering BC

ASM Microbe 2017 - Jonathan D. Edwards, PharmD: Antifungal Stewardship

ASM Microbe 2017 - Jonathan D. Edwards, PharmD: Antifungal Stewardship

ASM Microbe 2017 - Jonathan D. Edwards, PharmD: Grasping at Straws

ASM Microbe 2017 - Jonathan D. Edwards, PharmD: Grasping at Straws

ASM Microbe 2017 - Jonathan D. Edwards, PharmD: Patients Missed by Blood Culture

ASM Microbe 2017 - Jonathan D. Edwards, PharmD: Patients Missed by Blood Culture

ASM Microbe 2017 - Jonathan D. Edwards, PharmD: Impact on Negative Patients

ASM Microbe 2017 - Jonathan D. Edwards, PharmD: Impact on Negative Patients

ASM Microbe 2017 - Jonathan D. Edwards, PharmD: Superior Results with T2Candida

ASM Microbe 2017 - Jonathan D. Edwards, PharmD: Superior Results with T2Candida

ASM Microbe 2017 - Jonathan D. Edwards, PharmD: Why T2 at Huntsville

ASM Microbe 2017 - Jonathan D. Edwards, PharmD: Why T2 at Huntsville

ASM Microbe 2017 - Mitchell J. Cohen, MD: Rapid, Blood Culture-Free Sepsis Diagnostics in the ED

ASM Microbe 2017 - Mitchell J. Cohen, MD: Rapid, Blood Culture-Free Sepsis Diagnostics in the ED

ASM Microbe 2017 - Managing Sepsis in the Golden Hour

ASM Microbe 2017 - Managing Sepsis in the Golden Hour

Introduction to T2Candida

Introduction to T2Candida

T2Candida Economic Impact

T2Candida Economic Impact

How T2MR Works

How T2MR Works

Real World Experience with the T2Candida Panel

Real World Experience with the T2Candida Panel

T2Candida Panel

T2Candida Panel